Innovation
12 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 223 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 3 |
Social engagement
Social engagement: 13.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Sofinnova Partners, Carbyne Equity Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Private equity | 3 | 38% |
| Accelerator & incubator | 1 | 13% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 1 | 13% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
22 Jan 2025 · Commercial Director EU (F/M) · Paris
Based on job postings tracked across public sources.
Recent activity
17 Jun 2026
Product launch
regulatory
5 Jun 2026
Partnership
Bayer